Brief: Active Biotech Q4 Operating Loss Narrows To SEK 4.1 Million

Active Biotech AB publ

11/02/2021 07:35

Feb 11 (Reuters) - Active Biotech AB (publ)  ACTI.ST :
    * REG-ACTIVE BIOTECH YEAR-END REPORT JANUARY – DECEMBER 2020
    * Q4 NET SALES SEK 6.2 MILLION VERSUS SEK 0.9 MILLION YEAR
AGO
    * Q4 OPERATING LOSS SEK 4.1 MILLION VERSUS LOSS SEK 11.2
MILLION
YEAR AGO

Source text for Eikon:  ID:nGNEbPMX3M 
Further company coverage:  ACTI.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))